Patent details

EP3620534 Title: CRISPR-CAS COMPOSITIONS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS

Basic Information

Publication number:
EP3620534
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP191886241
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRISPR-CAS COMPOSITIONS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS
French Title of Invention:
CRISPR-CAS COMPOSITIONS POUR DES ACIDES NUCLÉIQUES À CIBLAGE D'ACIDE NUCLÉIQUE
German Title of Invention:
CRISPR-CAS ZUSAMMENSETZUNGEN ZUM TARGETING VON NUKLEINSÄUREN DURCH NUKLEINSÄUREN
SPC Number:

Dates

Filing date:
12/03/2014
Grant date:
13/10/2021
EP Publication Date:
11/03/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/10/2021
EP B1 Publication Date:
13/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/03/2022
Expiration date:
12/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/10/2021
 
 

Name:
Caribou Biosciences, Inc.
Address:
2929 7th Street Suite 105, Berkeley, CA 94710, United States (US)

Inventor

1

Name:
BERGER, James, M.
Address:
United States (US)

2

Name:
HAURWITZ, Rachel, E.
Address:
United States (US)

3

Name:
DOUDNA, Jennifer, A.
Address:
United States (US)

4

Name:
MAY, Andrew, Paul
Address:
United States (US)

5

Name:
CARTER, Matthew, Merrill
Address:
United States (US)

6

Name:
DONOHOUE, Paul
Address:
United States (US)

Priority

1

Priority Number:
201361781598 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

2

Priority Number:
201361818386 P
Priority Date:
01/05/2013
Priority Country:
United States (US)

3

Priority Number:
201361818382 P
Priority Date:
01/05/2013
Priority Country:
United States (US)

4

Priority Number:
201361822002 P
Priority Date:
10/05/2013
Priority Country:
United States (US)

5

Priority Number:
201361832690 P
Priority Date:
07/06/2013
Priority Country:
United States (US)

6

Priority Number:
201361845714 P
Priority Date:
12/07/2013
Priority Country:
United States (US)

7

Priority Number:
201361858767 P
Priority Date:
26/07/2013
Priority Country:
United States (US)

8

Priority Number:
201361859661 P
Priority Date:
29/07/2013
Priority Country:
United States (US)

9

Priority Number:
201361865743 P
Priority Date:
14/08/2013
Priority Country:
United States (US)

10

Priority Number:
201361883804 P
Priority Date:
27/09/2013
Priority Country:
United States (US)

11

Priority Number:
201361899712 P
Priority Date:
04/11/2013
Priority Country:
United States (US)

12

Priority Number:
201361900311 P
Priority Date:
05/11/2013
Priority Country:
United States (US)

13

Priority Number:
201361902723 P
Priority Date:
11/11/2013
Priority Country:
United States (US)

14

Priority Number:
201361903232 P
Priority Date:
12/11/2013
Priority Country:
United States (US)

15

Priority Number:
201361906335 P
Priority Date:
19/11/2013
Priority Country:
United States (US)

16

Priority Number:
201361906211 P
Priority Date:
19/11/2013
Priority Country:
United States (US)

17

Priority Number:
201361907216 P
Priority Date:
21/11/2013
Priority Country:
United States (US)

18

Priority Number:
201361907777 P
Priority Date:
22/11/2013
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/6818; C12Q 1/6806; C12Q 1/6869; C12N 9/22; C12N 15/113; C12N 15/52; C12N 15/10;

Publication

European Patent Bulletin

Issue number:
202141
Publication date:
13/10/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages